Trial NCT01484041

View at ClinicalTrials.gov 
Org. Study IDs: LCCC 2010-535

Last trial update was posted on 2018-02-09

MeSH Interventions

Aromatase Inhibitors

MeSH Conditions

Breast Neoplasms

Other Conditions

Breast Cancer

Stopping Reasons

Decision by company to cease development of dovitinib

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID